Immunity Boosting Food Product Industry SWOT Analysis, Size, Share, Price, Trends and Growth Forecast to 2025

Immunity Boosting Food Product -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025

PUNE, MAHARASHTRA, INDIA, October 20, 2020 /EINPresswire.com/ — Immunity Boosting Food Product Industry

Description

Wiseguyreports.Com Adds “Immunity Boosting Food Product -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025” To Its Research Database

Immunity Boosting Food Product market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Immunity Boosting Food Product market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

In the competitive analysis section of the report, leading as well as prominent players of the global Immunity Boosting Food Product market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

The key players covered in this study

Danone SA
Nestle
Blue Diamond Growers
Diamond Foods
Dole Food Company
Pinnacle Foods
Olam International
Hines Nut Company
Fonterra Group Cooperative

Request For Sample Report @ https://www.wiseguyreports.com/sample-request/5559318-global-immunity-boosting-food-product-market-size-status-and-forecast-2020-2026

Market segment by Type, the product can be split into
Nuts and Seeds
Fruits and Vegetables
Dairy-based Products
Probiotics and Prebiotics
Others

Market segment by Application, split into
Online
Offline

Based on regional and country-level analysis, the Immunity Boosting Food Product market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

Leave a Query @ https://www.wiseguyreports.com/enquiry/5559318-global-immunity-boosting-food-product-market-size-status-and-forecast-2020-2026

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunity Boosting Food Product Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Nuts and Seeds
1.2.3 Fruits and Vegetables
1.2.4 Dairy-based Products
1.2.5 Probiotics and Prebiotics
1.2.6 Others
1.3 Market by Application
1.3.1 Global Immunity Boosting Food Product Market Share by Application: 2020 VS 2026
1.3.2 Online
1.3.3 Offline
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Immunity Boosting Food Product Market Perspective (2015-2026)
2.2 Global Immunity Boosting Food Product Growth Trends by Regions
2.2.1 Immunity Boosting Food Product Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Immunity Boosting Food Product Historic Market Share by Regions (2015-2020)
2.2.3 Immunity Boosting Food Product Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

11Key Players Profiles
11.1 Danone SA
11.1.1 Danone SA Company Details
11.1.2 Danone SA Business Overview
11.1.3 Danone SA Immunity Boosting Food Product Introduction
11.1.4 Danone SA Revenue in Immunity Boosting Food Product Business (2015-2020))
11.1.5 Danone SA Recent Development
11.2 Nestle
11.2.1 Nestle Company Details
11.2.2 Nestle Business Overview
11.2.3 Nestle Immunity Boosting Food Product Introduction
11.2.4 Nestle Revenue in Immunity Boosting Food Product Business (2015-2020)
11.2.5 Nestle Recent Development
11.3 Blue Diamond Growers
11.3.1 Blue Diamond Growers Company Details
11.3.2 Blue Diamond Growers Business Overview
11.3.3 Blue Diamond Growers Immunity Boosting Food Product Introduction
11.3.4 Blue Diamond Growers Revenue in Immunity Boosting Food Product Business (2015-2020)
11.3.5 Blue Diamond Growers Recent Development
11.4 Diamond Foods
11.4.1 Diamond Foods Company Details
11.4.2 Diamond Foods Business Overview
11.4.3 Diamond Foods Immunity Boosting Food Product Introduction
11.4.4 Diamond Foods Revenue in Immunity Boosting Food Product Business (2015-2020)
11.4.5 Diamond Foods Recent Development
11.5 Dole Food Company
11.5.1 Dole Food Company Company Details
11.5.2 Dole Food Company Business Overview
11.5.3 Dole Food Company Immunity Boosting Food Product Introduction
11.5.4 Dole Food Company Revenue in Immunity Boosting Food Product Business (2015-2020)
11.5.5 Dole Food Company Recent Development
11.6 Pinnacle Foods
11.7 Olam International
11.8 Hines Nut Company
11.9 Fonterra Group Cooperative
11.10 Associated British Foods

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=5559318

Continued…           

Contact Us: Sales@Wiseguyreports.com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349
email us here


Source: EIN Presswire

Aldevron Promotes Venkata Indurthi to Vice President of Research and Development

Headshot of Venkata Indurthi, Vice President of Research and Development at Aldevron

Venkata Indurthi, Vice President of Research and Development

Aldevron, a global leader in the manufacture of plasmid DNA, mRNA and proteins, has promoted Venkata Indurthi to Vice President of Research and Development.

I am grateful to be part of a company that has redefined the boundaries of biologics manufacturing. I will build upon that legacy and create a team that will be a nucleus of innovation for Aldevron.”

— Venkata Indurthi

FARGO, NORTH DAKOTA, UNITED STATES, October 20, 2020 /EINPresswire.com/ — Aldevron, a global leader in the manufacture of plasmid DNA, mRNA and proteins, has promoted Venkata Indurthi to Vice President of Research and Development (R&D). He will begin this new role immediately and continue reporting to John Ballantyne, Co-founder and Chief Scientific Officer while having direct access to Aldevron’s senior executive team.

Indurthi will lead Aldevron’s team of scientists as they undertake new ways to innovate and introduce products and services to clients. He will also serve as operational lead for all RNA-focused developments, arguably the most promising technique to solve major worth health challenges. Indurthi will provide essential leadership and structure while focusing on strategic opportunities to help further establish Aldevron as an R&D leader, to help grow sales and to foster long-term relationships in the U.S. and global markets.

“Venkata joined Aldevron in 2015, bringing a natural acumen for science and inherent ability to see possibility,” said John Ballantyne. “He led the charge for our RNA manufacturing process, bringing Aldevron to a leadership position in the industry. As Vice President of R&D, I am confident that our team will thrive under his leadership thanks to his client-centric approach, and his passion for developing new ways to solve problems. He is the absolute right person for this new role.”

After stints as a research intern at Veer Chemie & Aromatics Limited and the National Institute of Nutrition, both in Hyderabad, India, Indurthi became a graduate research assistant at North Dakota State University (NDSU), where he also earned his PhD in Pharmaceutical Sciences. He started his career with Aldevron as a QC Scientist, followed by a position as Senior Scientist in Product and Process Design, Director of R&D and most recently as Director of RNA Operations.

“I am grateful to be part of a company that has redefined the boundaries of biologics manufacturing,” said Indurthi. “In my new role, I will build upon that legacy and create a team that will be a nucleus of innovation for Aldevron.”

Aldevron’s values include serving clients and the industry through collaboration, focusing on the best outcome; a mindset that is pervasive with all staff. “Venkata has demonstrated his passion for the work and for Aldevron every day since he has started,” said Kevin Ballinger, CEO of Aldevron. “This promotion is well deserved, and I look forward to witnessing the new heights our R&D team will reach under his leadership.”

Indurthi graduated with B.S. degree in Biotechnology from SRM University, Chennai, India, and his PhD in Pharmaceutical Science from NDSU.

ABOUT ALDEVRON
Aldevron serves the biotechnology industry with custom production of nucleic acids and proteins. Thousands of clients use Aldevron-produced plasmids, RNA and gene editing enzymes for projects ranging from research grade to clinical trials to commercial applications. The Company specializes in GMP manufacturing and is known for inventing the GMP-Source® quality system. Aldevron’s 14-acre campus headquarters is located in Fargo, N.D. and is the world’s largest DNA and RNA manufacturing facility. The company’s protein development and manufacturing operations are located in Madison, WI.

Ellen Shafer
Aldevron
+1 701-551-8704
email us here


Source: EIN Presswire

Hemp Rivers Aquaponics Ltd Enters Into An Agreement With 1151555 B.C. Ltd. To Negotiate Terms For A Business Combination

Hemp Rivers Aquaponics Ltd Logo

Hemp Rivers Aquaponics Ltd Logo

We are pleased to work with Rahim Mohamed and his team to investigate the possible merger. Their commitment and plans for future growth align with Hemp River’s management’s business objectives.”

— Sage Ellie, CEO of Hemp Rivers

VANCOUVER, B.C., CANADA, October 20, 2020 /EINPresswire.com/ — Hemp Rivers Aquaponics Ltd. ("Hemp Rivers"), a private British Columbia company, is pleased to announce it has entered into a Memorandum of Understanding (the "MOU") dated October 6, 2020 with 1151555 B.C. Ltd. ("555"), a British Columbia company, to exclusively explore and evaluate a proposed business combination.

Pursuant to the terms of the MOU, Hemp Rivers and 555 have agreed to work together to explore and evaluate the proposed business combination to be effected by way of a share exchange whereby 555 will acquire all of the Issued and outstanding shares in the capital of Hemp Rivers in exchange for the Issuance of shares in the capital of 555 (the "Potential Transaction"). The parties will continue to work in good faith to settle more definitive terms of the Potential Transaction to be encapsulated in a Letter of Intent. If, and when, the Potential Transaction is completed, it is anticipated that the shareholders of Hemp Rivers, in the aggregate, owning the majority of the shares in the capital of 555. The Letter of Intent will outline customary representations, warranties and conditions precedent to the completion of the Potential Transaction, which will be mutually agreed upon between the parties. Although Hemp Rivers are hopeful that the parties will enter into a Letter of Intent, and subsequently a definitive agreement, there can be no guarantee that the Potential Transaction will be completed, if at all.

Sage Ellie, CEO of Hemp Rivers stated, “We are pleased to work with Rahim Mohamed and his team to investigate the possible merger. Their commitment and plans for future growth align with Hemp River’s management’s business objectives.”

Except for the parties agreeing not to discuss a potential business combination with any other parties, the MOU is non-binding and remains valid until the earlier of June 1, 2021, or until the Letter of Intent between the parties is signed.

About Hemp Rivers Aquaponics Ltd.
Hemp Rivers' Mission is to consistently provide CBD processors with a superior crop of medical-grade high CBD – hemp on an environmentally sustainable basis. Hemp Rivers has planned to develop and operate its first aquaponics farm from a Greenz AgriTech Innovation Park. Greenz Parks is affiliated with Green Oasis Foods Ltd. and Greenz Markets.

Disclaimer for Forward-Looking Information
Certain statements in this press release include "forward-looking statements" and "forward-looking information" under applicable Canadian securities laws that are not historical facts. Forward-looking statements involve risks, uncertainties, and other factors that could cause actual results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements in this news release include, but are not limited to: Hemp Rivers and Hemp River's business and prospects; Hemp River's objectives, goals or future plans; future growth, the completion of the Potential Transaction, the execution of the Letter of Intent, and the entering into the definitive agreement. Forward-looking statements are necessarily based on a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic and social uncertainties; local and global market and economic uncertainties arising in respect of the COVID-19 pandemic, litigation, legislative, environmental and other judicial, regulatory, political and competitive developments; the ability to effectively expand manufacturing and production capacity; the success of market initiatives and the ability to grow brand awareness; and the sufficiency of our cash to meet liquidity needs. Accordingly, the forward-looking statements discussed in this news release may not occur and could differ materially as a result of these known and unknown risk factors and uncertainties affecting Hemp Rivers. Although Hemp Rivers believes that the assumptions and factors used in preparing the forward-looking statements are reasonable, readers are cautioned not to place undue reliance on forward-looking statements, which only apply as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Except where required by law, Hemp Rivers disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Source Hemp Rivers Aquaponics Ltd.

Media Contact Victoria Bennett, Bennett Milner Williams Consulting Ltd. 403 589 7992 victoria@bmwconsults.com

Victoria Bennett
Bennett Milner Williams Consulting Ltd
+1 403-589-7992
email us here


Source: EIN Presswire

OnMed ® and Connecting World Merchandise expand availability of revolutionary telemedicine station

The future of healthcare has arrived. The patented OnMed® Station instantly connects patients with live Nurses, Doctors, and Pharmacists to deliver affordable, quality healthcare to everyone

This reminds me of something out of the Jetsons. It is game-changing technology that addresses the coronavirus pandemic and tackles the lack of access to high-quality healthcare impacting our nation.”

— Pro Football Hall of Famer, Bobby Bell

TAMPA, FLORIDA, UNITED STATES, October 20, 2020 /EINPresswire.com/ — The future of healthcare has arrived. The patented OnMed® Station instantly connects patients with live Nurses, Doctors, and Pharmacists to deliver affordable, quality healthcare to everyone. Using advanced patented technologies, FDA cleared diagnostics, high-definition thermal imaging, and robotics for dispensing certain prescription medications onsite, OnMed® has created the first-of-its kind telemedicine station.

“This reminds me of something out of the Jetsons. It is game-changing technology that addresses the coronavirus pandemic and tackles the lack of access to high-quality healthcare impacting our nation,” said Pro Football Hall of Famer, Bobby Bell – Connecting World Merchandise director of promotions. “The futuristic technology is extremely advanced but it’s easy to use. You can walk in, push one button, up comes the doctor, you get a diagnosis and walk away with your medication.”

This station can provide students, employees, airport travelers and others same day and after-hours doctor’s visits that are not urgent without exposing high-risk patients or tying up critical resources in emergency rooms. It’s an ideal complement to the existing network of outpatient clinics. Clinicians can conduct consultations in multiple languages, including Spanish and American Sign Language, and can dispense up to 200 common medications on-site.

The OnMed® Station provides patients with a live virtual consultation with a licensed clinician who can make a diagnosis and prescribe medications. Features and services of the station include:

● Vitals like height, weight and blood pressure
● Thermal imaging to provide body temperature and diagnose infection
● Readings of respiration and blood oxygen saturation
● An FDA approved high-definition camera so physicians can conduct visual assessments to assist with diagnosis.
● Transmission of results to the patient’s primary care physician
● Availability of a rapid COVID-19 test
● Stethoscope for heart & lung sounds and an Otoscope for internal ear exams

After every patient visit, the OnMed® station is thoroughly cleaned using high-output ultraviolet
surface and air sanitization.

“This is the perfect example of how technology can be used to address the most pressing health care needs of our time,” said Austin White, founding partner and CEO of OnMed®. “Our stations can be located where they are needed most and go well beyond just a phone call. OnMed® offers a live face-to-face visit using the latest diagnostic tools. It’s transformative technology that improves access and quality of care.”

About Connecting World Merchandise (CWM)
Connecting World Merchandise, LLC is an innovative global wholesaler who provides best in class products designed to serve the current and changing needs of wholesalers and brokers around the globe. Its focus is on leveraging its manufacturing relationships to help wholesalers and brokers provide the best possible prices, product lines, innovative solutions, and options for their customers. It exists to provide end-to-end solutions to serve the world’s population. Learn more at www.staysafe.works.

About OnMed
OnMed is committed to providing quality, affordable health care solutions through technology and innovation. Based in Tampa, Florida, the company’s leadership has decades of combined experience in healthcare in all 50 states and Puerto Rico. In 2019, the company introduced the world’s only self-contained telehealth station. It offers secure, private, virtual doctor’s visits and basic exams, and dispenses 200 common medications. The OnMed stations are manufactured in Florida, sourcing as many parts as possible in the United States. Partnerships with Samsung and Intel ensure the highest quality video and audio experience for users.

###

Mark Molzen
Connecting World Merchandise, LLC
+1 602-614-7476
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Colorado US Navy Veterans Lung Cancer Advocate Is Urging a VFW Member Who Has a Navy Veteran Friend with Lung Cancer in Colorado to tell his Wife to Call the Lawyers at KVO About Compensation-If he Had Asbestos Exposure

"Most Navy Veterans who now have lung cancer-and who had significant exposure to asbestos in the navy are not aware the $30 billion dollar-asbestos trust funds were set up for them too. ”

— Colorado US Navy Veterans Lung Cancer Advocate

DENVER, COLORADO , USA, October 20, 2020 /EINPresswire.com/ — The Colorado US Navy Veterans Lung Cancer Advocate is urging a member of the American Legion or VFW who has a Navy Veteran friend with lung cancer to please ask him if he had significant exposure to asbestos in the navy. If the answer is yes–please ask-his wife or family to call the lawyers at Karst von Oiste-KVO about compensation at 800-714-0303. Compensation for a person like this might exceed $100,000 and the financial compensation claim does not involve suing the navy. The typical person the Advocate is trying to identify is over 60 years old and their asbestos exposure took place prior to 1982. www.karstvonoiste.com/

The Advocate says, "Most Navy Veterans who now have lung cancer-and who had significant exposure to asbestos in the navy are not aware the $30 billion dollar-asbestos trust funds were set up for them too. If this sounds like a friend-please tell their family to call the lawyers at the law firm of Karst von Oiste-KVO at 800-714-0303. Financial compensation might be significant." www.karstvonoiste.com/

The Colorado US Navy Veterans Lung Cancer Advocate’s free services are available to people with asbestos exposure lung cancer or mesothelioma in Denver, Colorado Springs, Aurora, Fort Collins, Lakewood, Thronton, Pueblo, Greeley or anywhere in Colorado. https://Colorado.USNavyLungCancer.Com

High-risk work groups for exposure to asbestos in Colorado include US Navy Veterans, workers at Fort Carson, or Cheyenne Mountain, workers at one of Colorado’s 12 coal fired power plants, miners, manufacturing workers, public utility workers, plumbers, electricians, auto mechanics, machinists, or construction workers. In most instances, these types of workers were exposed to asbestos in the 1950’s, 1960’s, 1970’s, or 1980’s. https://USNavyLungCancer.Com

According to the American Cancer Society for nonsmokers who have been exposed to asbestos in their workplace the risk of lung cancer is five times that of unexposed workers. https://www.cdc.gov/cancer/lung/statistics/index.htm.

The US Navy Veterans Lung Cancer Advocate says, “If your husband, dad, coworker or neighbor has just been diagnosed with lung cancer and you know they had significant exposure to asbestos in the navy, at a shipyard or while working at a factory, at power plant, public utility, or as a plumber, electrician welder, mechanic or any kind of skilled trades group in any state please have them call us anytime at 800-714-0303. Most people like this never get compensated-even though the asbestos trust funds were set up for them too. We are trying to change this sad fact.” https://USNavyLungCancer.Com

States with the highest incidence of lung cancer include Kentucky, West Virginia, Maine, Tennessee, Mississippi, Ohio, Indiana, Louisiana, Arkansas, Missouri, North Carolina, Rhode Island, Alabama, and Delaware. However, there are people with asbestos exposure lung cancer in Colorado. www.karstvonoiste.com/

For more information about asbestos exposure please visit the NIH’s website on this topic:
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/asbestos/asbestos-fact-sheet.

Michael Thomas
Colorado US Navy Veterans Lung Cancer Advocate
+1 800-714-0303
email us here


Source: EIN Presswire

Small Retail Pharmacies likely targets of Larger Chains in Malaysia Retail Pharmacy Market: Ken Research

Malaysia Retail Pharmacy Market

Malaysia Retail Pharmacy Market

Malaysia Retail Pharmacy Market Infographic

Malaysia Retail Pharmacy Market Infographic

Malaysia Pharmacy Retail market in terms of revenue increased at a single digit CAGR over the review period 2013-2019.

MALAYSIA, October 20, 2020 /EINPresswire.com/ — • MCO movement in Malaysia amidst COVID-19 reduced number of operating hours of Pharmacies but resulted in an increase of ~15% in online delivery for product categories majorly Personal Care, Sanitizers and Nutrition & Health Supplements.
• The Malaysian Cabinet with aim of reducing costs to customers introduced External Reference Pricing policy in May ‘19 to benchmark drug prices at wholesale and retail levels. However, the policy reduced trade margins for drugs in the country and led to a cascading effect to all the pharmacy players in the country.
• Healthcare spending in 2019 accounted for 10% of total budget of Malaysia wherein government’s goal is to achieve the long term growth to be aligned with the WHO recommended healthcare spending of 7% of GDP.

Growing Number of Licences issued: Cumulative number of License A/B/E and NaOH issued under the Poison Act 1952 by the Pharmacy Enforcement is persistently increasing from approximately 9,000 in 2017 to more than 10,000 in 2019 wherein more than 50% of the total license issued in 2019 was accounted by License A, which is issued to a pharmacist to import, store and deal generally by wholesale and retail or by wholesale only or by retail only.

For more information on the research report, refer to below link:

https://www.kenresearch.com/healthcare/pharmaceuticals/malaysia-pharmacy-retail-market-outlook-to-2025/353094-91.html

Consolidation of Pharmacies: Larger and mid-sized pharmacy retail chains in the industry are expanding organically by acquiring or merging with smaller chains and independent stores either to enhance their geographical presence or to increase their product & service portfolio. Some recent mergers include Health Lane Family Pharmacy Sdn Bhd buying over Kumpulan Farmasi Vitacare Sdn Bhd and acquisition of Caring Pharmacy by 7 Eleven group in Malaysia.

Collaborations & Partnerships: Partnerships of pharmacies with online consultation & e-prescription companies is growing in Malaysia as Telemedicine Blueprint envisioned that by 2020, the healthcare system of the country would be transformed with developments of advanced health systems by harnessing the power of information & multimedia technologies. Amidst the COVID pandemic, health care providers observed a shift in consumer behaviour, where people are now accepting more digital services such as tele consultation, medication delivery & Covid-19 screening services.

Analysts at Ken Research in their latest publication “Malaysia Pharmacy Retail Market Outlook to 2025– By Market Structure (Organized & Unorganized), By Location (Mall Based & High Street), By Product Sales (Prescribed Drugs, Generics, Non Pharmaceutical Products, Medical Equipments), By Drug Type (Patented & Generics) and By Therapeutic Areas”, the Malaysia Retail Pharmacy Market has been increasing due to increasing geographical presence of pharmacy outlets, rising number of pharmacists along with expansion in value added services offered by major players to sustain and increase their user base in the country. The market is expected to register a positive CAGR of 9.3% in terms of revenue during the forecast period 2020-2025.

Key Segments Covered

• By Market Structure (Number of Pharmacy Outlets & Revenue in USD Mn)

 Organized
o Organized Mall Based
o Organized High Street Stores

 Unorganized
o Unorganized Mall Based
o Unorganized High Street

• By Location (Number of Pharmacy Outlets & Revenue in USD Mn

 Mall Based
o Prescribed Drugs
o Over-The-Counter
o Non Pharmaceutical Products
o Medical Equipments

 High Street
o Prescribed Drugs
o Over-The-Counter
o Non Pharmaceutical Products
o Medical Equipments

• By Product Sales
 Prescribed Drugs
 Over-The-Counter
 Non Pharmaceutical Products
 Medical Equipments

• By Sales
 Patented Drugs
 Generics

• By Region
 Selangor
 Johor
 Kuala Lumpur
 Sarawak
 Others

• By Therapeutic Areas
 Anti-Infective
 Cardiovascular
 Pain/Analgesics
 Vitamins/Minerals/Nutrients
 Antibiotic
 Respiratory
 Gastro Intestinal
 Gynaecology
 Neuro
 Others

Companies Covered
• Watsons Malaysia
• Guardian Pharmacy
• Caring Pharmacy
• Alpro Pharmacy
• Healthlane Pharmacy
• Multicare Pharmacy
• AM PM Pharmacy
• Cosway Farmasi
• Aeon Wellness
• AA Pharmacy

Key Target Audience
• Pharmaceutical Manufacturing Companies
• Pharmacy Retail Companies
• Independent Pharmacies
• Industry Associations
• Regulatory Bodies
• Telemedicine Companies
• Pharmaceutical Distributors & Wholesalers

Time Period Captured in the Report:-
• Historical Period: 2013-2019
• Forecast Period: 2020-2025

Key Topics Covered in the Report
• Overview of Malaysia Pharmacy Retail Market
• Trends and Growth Drivers in the Industry and Challenges Faced
• Malaysia Pharmacy Retail Market Size and Segmentations, 2013 – 2019
• Ecosystem and Value Chain of Pharmacy Retail Market in Malaysia
• Distributors & Wholesalers Landscape in Malaysia Pharmacy Retail Market
• Industry SWOT Analysis and BCG Matrix
• Telemedicine & Online Consultations Snapshot
• Contraceptive Demand among Customers in Malaysia
• Cross Comparison between Major Players and Company Profiles
• Future Market Size and Segmentations, 2020P-2025F
• Covid-19 Impact on the Industry & the Way Forward
• Analysts’ Recommendations

For more information on the research report, refer to below link:

https://www.kenresearch.com/healthcare/pharmaceuticals/malaysia-pharmacy-retail-market-outlook-to-2025/353094-91.html

Related Reports

https://www.kenresearch.com/healthcare/pharmaceuticals/india-e-pharmacy-competition-benchmarking/345912-91.html

https://www.kenresearch.com/healthcare/pharmaceuticals/kuwait-retail-pharmacy-market/175024-91.html

https://www.kenresearch.com/healthcare/diagnostics/india-diagnostic-laboratories-market-outlook/336548-91.html

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

Ankur Gupta
Ken Research Private limited
+91-9015378249
ankur@kenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

KenSci and Brown Smith Wallace Partner to Drive Transformation in Healthcare

Both organizations bring strengths in process strategy and technology to improve revenue cycle management to create value for the healthcare industry.

SEATTLE, WASHINGTON, UNITED STATES, October 20, 2020 /EINPresswire.com/ — KenSci, an AI-based platform for healthcare, and Brown Smith Wallace (BSW), a top 100, full-service CPA and business advisory firm, today announced a strategic partnership designed to drive business process transformation for healthcare businesses. The two companies will fuse their collective expertise in advanced artificial intelligence and business performance to improve revenue cycle management for hospitals, healthcare systems, provider groups and others.

“COVID-19 has created unique challenges for healthcare revenue cycle and financial operations, driving the need for analytics and AI-assisted revenue management,” commented Sunny Neogi, chief growth officer at KenSci. “We are delighted to combine forces with BSW to enable health systems bring analytics and AI insights to their revenue cycle workflows, accelerating the transformation of healthcare processes and addressing the perpetual need for revenue recovery.”

According to the American Hospital Association, U.S. hospitals are expected to lose more than $323 billion this year due to the pandemic. Health systems have pivoted to create capacity to treat critically ill patients while reducing or suspending elective medical procedures, non-elective surgeries, outpatient treatment and emergency department services. This focus on COVID-19 patients, combined with the loss of other revenue streams, has put additional pressure on already strained healthcare systems.

This new partnership aims to integrate the superior capabilities of KenSci’s AI Platform for Digital Health, BSW’s process strategy expertise, and both organizations’ healthcare industry knowhow to create efficiencies that increase revenue and improve profitability. The combined solution will enable health systems to manage risk across their operations with predictive solutions in areas such as:
• First payment and days in A/R
• Fraud, waste and abuse
• Suspect diagnosis and medical coding
• Estimating patient liability

“The disruption that COVID-19 has created within the economy has been especially acute in the healthcare industry,” says David Contrera, principal, Advisory Services at Brown Smith Wallace. “The pandemic has accelerated the need to transform and exacerbated the challenges associated with legacy processes. Our partnership brings together cutting-edge technology and proven process strategy to help health systems maximize revenue opportunities today and prepare for more efficient and profitable growth in the future.”

ABOUT KENSCI
KenSci's AI Platform for Digital Health enables healthcare organizations bring analytics and artificial intelligence at the core of their operational, clinical and care workflows, improving care experience and health outcomes. KenSci accelerates business transformation for health providers, payors, medical device and other healthcare organizations, delivering mission critical insights in real-time to improve care quality while reducing healthcare costs. With KenSci's AI Platform that integrates latest descriptive and predictive analytics technology, health organizations can rapidly develop, deploy and manage analytics and AI use-cases to modernize their workflows and power a digital, data-driven, value-based healthcare system. By making AI use in health systems more explainable, interpretable and assistive, KenSci is helping healthcare become more efficient and accountable.

KenSci was incubated at University of Washington's Center for Data Science at UW Tacoma and designed on the cloud with help from Microsoft's Azure4Research grant program. KenSci is headquartered in Seattle, with offices in Singapore and Hyderabad. For more information, visit www.kensci.com

ABOUT BROWN SMITH WALLACE
We are a nationally ranked, top 100, full-service CPA and business advisory firm and an independent member firm of Moore North America. We are recognized as an INSIDE Public Accounting 2020 Best of the Best Firm for our performance in management, growth and strategic vision.

In addition to traditional audit, accounting and tax services, the firm provides private and public companies with value-added business consulting services, including software evaluation and selection, data analysis, cybersecurity services and business performance consulting.

Our business performance consultants work with organizations to analyze current operations and find opportunities to reduce waste, improve efficiency and effectiveness, and support the growth and evolution of the organization. Areas of focus include cash flow optimization; sourcing and contracting; and accounting closing, consolidation and reporting.
Learn more at brownsmithwallace.com

Abhilash Kumar
KenSci
+91 98458 72451
email us here


Source: EIN Presswire

Sahara Group urges global private sector collaboration to boost food security

Farmers, stakeholders at the Food Africa Launch in Kaduna

Sahara Group has canvassed increased private sector collaboration towards optimising food value chains to address global undernourishment prevalence

Sahara Group is already witnessing how effective multi-stakeholder cooperation can be with the ongoing implementation of the Food Africa project”

— Pearl Uzokwe, Director, Governance and Sustainability, Sahara Group

LAGOS, NIGERIA, October 20, 2020 /EINPresswire.com/ — Leading energy conglomerate, Sahara Group has canvassed increased private sector collaboration towards optimising food value chains to address global undernourishment prevalence which stands at 687.8 Million (8.9% of global population), according to the Food and Agricultural Organisation 2020 report on the state of food security and nutrition in the world.

The FAO report also recorded the prevalence of severe food insecurity at 746.0 Million, which translates to 9.7% of global population. Further review of the report shows that sub-Saharan Africa alone has severe food insecurity prevalence of 227.5 Million, which is 21.3% of African population. The report cites undernourishment as a measure of the insufficiency of an individual’s food consumption to provide the amount of dietary energy required to maintain a normal, active and healthy life, while food insecurity, refers to limited access to food, at the level of individuals or households, due to lack of money or other resources.

Pearl Uzokwe, Sahara Group’s Director of Governance and Sustainability said collaboration among regional and global businesses will increase investments in sustainable food and agricultural projects and create avenues for better engagement with governments and global development agencies.
She said the requirement for global healthy diet cost estimated at $3.75/person/day and $3.84/person/day makes achieving nutritious food for all a herculean task given that the cost of a healthy diet exceeds the international poverty line (established at USD 1.90 purchasing power parity (PPP) per person per day.

“The covid-19 pandemic has shown how much progress we can all make when businesses toe the path of collaboration. Addressing food security across the globe is a quest that requires urgent attention to ensure that no individual is left behind. Sahara Group is already witnessing how effective multi-stakeholder cooperation can be with the ongoing implementation of the Food Africa project,” she said.

According to Uzokwe, increased investment will help address low levels of productivity, high production risks, insufficient diversification towards more nutritious foods and lack of physical access to food markets.

She noted that collaboration will also facilitate the emergence of vibrant trade policies that will give traction to food production, improve food safety and quality standards. “We will ultimately move the world towards robust food value chains that will enhance food storage, road infrastructure, and food preservation capacity where heart breaking losses exist for highly perishable foods,” she added.

The Food Africa Project is a collaborative initiative between Sahara Group, United Nation- Sustainable Development Goals-Fund (SDG-F), Food and Agriculture Organization of the United Nations (FAO), the International Labour Organization (ILO), International Trade Centre (ITC), Roca Brothers and the Kaduna State Government, directed at empowering the people and alleviating poverty through food security.

Since 2016, a total of 388 farmers and other players directly benefitted from capacity building trainings along Horticultural value chain, Business development and Cooperative management, value addition and market linkages. More opportunity was given to youth and women participation in the trainings conducted (74%). 247 farmers operating under 15 cooperatives/farmer groups profiled by FAO were supported with agricultural implement which improved their productivity and minimized post-harvest losses.

Through value chain market programmes, 78 lead farmers, market agents and food processors (44 women) improved their knowledge of value addition, food safety, market development and linkages and off-farm opportunities. Farmers’ access to improved agro-processing and value chain integration would be further enhanced through the establishment of the food processing facility by Sahara Foundation.

Bethel Obioma
Sahara Group
+234 1 279 3811
email us here


Source: EIN Presswire

Malicious USB Spy Cables Detected by Murray Associates TSCM

The Malicious USB Spy Cable Test

Infrared Photo of Malicious USB Cable

Infrared Photo of Malicious USB Cable

Malicious USB Spy Cable Internet Ad

Malicious USB Spy Cable Internet Ad

Sharp spike in internet sales of USB spy cables has corporate security and IT directors concerned. Murray Associates researched and developed a solution.

Electronic eavesdropping and corporate espionage are covert activities. You need to inspect to detect. TSCM inspections are cheap insurance, but better. Insurance can't prevent the loss.”

— Kevin D. Murray, CPP, CISM, CFE

OLDWICK, NEW JERSEY, USA, October 20, 2020 /EINPresswire.com/ —
• Malicious USB cables look exactly like the real thing.
• Some act as eavesdropping bugs.
• Some have GPS tracking capability.
• The worst ones take control of a user’s cell phone, laptop, or desktop.

A malicious USB cable is any cable which performs an unexpected, and unwanted function. Data exfiltration, GPS tracking, and audio eavesdropping are the primary malicious functions Murray Associates TSCM discovered in their tests.

Murray Associates, a firm specializing in corporate counterespionage, noticed internet sales of these spy cables spiked this year. “The quality of these spy cables is amazing. Some are absolutely indistinguishable from the real thing just by looking,” said Kevin D. Murray, the firm’s Director. “Through testing we developed electronic detection techniques. This new protocol is now part of the Technical Surveillance Countermeasures (TSCM) inspections we conduct for our clients.”

Spy cables are very dangerous in a business environment. Placement is easy. Once in place they won’t be suspected. Discovery is impossible without inspection.

The worst malicious USB cables allow control of a user’s cell phone, laptop, or desktop by a remote hacker. This silent spying is of particular concern to corporations because this initial connection is often used as a pivot point to attack other machines and databases on the network. The hacker roams unnoticed on the network. Motives range from corporate espionage to instigating a ransomeware attack.

Some cables have an Achilles Heel. They become slightly warm when plugged into an active USB port. “We can easily see this using thermal imaging. Some people can detect it by touch. However, all USB cables should be considered suspect until we electronically test them,” said Murray. 


The first malicious USB cables began life as an NSA-created spy tool under the code name COTTONMOUTH in 2008. The government paid a lot for them. Their cost for a spy cable was $1,015.00 each, in quantities of 50. Now, malicious USB spy cables are universally available at a fraction of that cost; some costing less than $10.

Can’t identify the bugged cable? No worries. You can’t tell just by looking. That’s why we put a small black mark on it. It is Cable 3.
Malicious USB spy cables are only one corporate espionage trick spies use. There are many more. If your organization is concerned about electronic surveillance, information loss, or intellectual property theft, the counterespionage specialists at Murray Associates can help you.
In case you are interested in actually seeing malicious USB cables for sale, here are a few links… The o.mg cable. Alibaba
——

Kevin D. Murray CPP, CISM, CFE is a business counterespionage consultant and TSCM specialist with over four decades of experience.

Murray Associates is an independent security consulting firm, providing eavesdropping detection and counterespionage services to business, government and at-risk individuals.

Headquartered in the New York metropolitan area, a Murray Associates team can assist you quickly, anywhere in the United States, and internationally.

Kevin D. Murray
Murray Associates – TSCM
908-832-7900
tscm@counterespionage.com
Visit us on social media:
LinkedIn
Twitter


Source: EIN Presswire

Alaska US Navy Veterans Mesothelioma Advocate Urges the Family of a Navy Veteran in Alaska to Call Attorney Erik Karst of Karst von Oiste For His Expertise on Mesothelioma Compensation-Much Better Than a 'Free' Booklet

"To help a Navy Veteran with mesothelioma in Alaska we need their family to rally around their loved one-and to call attorney Erik Karst of Karst von Oiste at 800-714-0303-for better compensation. ”

— Alaska US Navy Veterans Mesothelioma Advocate

ANCHORAGE , ALASKA , USA, October 20, 2020 /EINPresswire.com/ — The Alaska US Navy Veterans Mesothelioma Advocate is urging the family of a Navy Veteran with mesothelioma in Alaska to please call attorney Erik Karst of the law firm of Karst von Oiste anytime at 800-714-0303 to get their specific questions answered about mesothelioma compensation. Rather than generic information offered in a 'free' booklet or publication about mesothelioma, and or mesothelioma compensation-attorney Erik Karst of Karst von Oiste will be able to explain how mesothelioma compensation works-as it will relate to the specific person. Erik Karst is one of the nation's leading mesothelioma attorneys. Mesothelioma compensation for a Navy Veteran can frequently exceed a million dollars. www.karstvonoiste.com/

The Advocate says, "Because of the Coronavirus many Navy Veterans with mesothelioma are not receiving their medical treatments, and in some instances-they are not pursuing compensation. The average age for a person with mesothelioma is 72 years old and by the time they get diagnosed they are typically very sick. To help a person like this in Alaska we need their family to rally around their loved one-and please call attorney Erik Karst of Karst von Oiste at 800-714-0303. The call is no obligation-and we believe it will be very informative and helpful." www.karstvonoiste.com/

The Alaska US Navy Veterans Mesothelioma Advocate’s free services are available to a Veteran with mesothelioma anywhere in the State of Alaska including Anchorage, Fairbanks, Juneau, Sitka, Ketchikan, Eagle River, Homer, Palmer or Nome. https://Alaska.USNavyMesothelioma.Com

For the best possible treatment options in Alaska we strongly recommend the following three heath care facilities with the offer to help a diagnosed victim, or their family get to the right physicians at each hospital.

* Alaska Regional Hospital-Anchorage: https://alaskaregional.com/.

* Providence Alaska Medical Center-Anchorage: https:// alaska.providence.org/locations/p/pamc.

* The University of Washington Cancer Clinic:
https://www.seattlecca.org/diseases/mesothelioma-overview.cfm

About one third of all US citizens diagnosed with mesothelioma each year are Veterans of the US Navy. Before a Navy Veteran with mesothelioma or their family retain the services of a lawyer or law firm, they are urged to call the US Navy Veterans Mesothelioma Advocate anytime at 800-714-0303. https://USNavyMesothelioma.Com

The states with the highest incidence of mesothelioma include Maine, Massachusetts, Connecticut, Maryland, New Jersey, Pennsylvania, Ohio, West Virginia, Virginia, Michigan, Illinois, Minnesota, Louisiana, Washington, and Oregon.

However, based on the calls the US Navy Veterans Mesothelioma advocate receives a US Navy Veteran diagnosed with mesothelioma could live in any state including New York, Florida, California, Texas, New Hampshire, Vermont, Iowa, Indiana, Missouri, Kentucky, Tennessee, North Carolina, Georgia, Alabama, Mississippi, Oklahoma, Arkansas, Nebraska, North Dakota, Montana, Wyoming, Colorado, Nevada, New Mexico, Utah, Arizona, Idaho, or Alaska. www.karstvonoiste.com/

For more information about mesothelioma please refer to the National Institutes of Health’s web site related to this rare form of cancer: https://www.cancer.gov/types/mesothelioma

Michael Thomas
Alaska US Navy Veterans Mesothelioma Advocate
+1 800-714-0303
email us here


Source: EIN Presswire